Senior Product Manger at Acadia Pharmaceuticals

Foster City, California, United States

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Rare DiseasesIndustries

Requirements

  • Bachelor’s degree in business, marketing, life sciences, or related field
  • 5+ years of experience in pharmaceutical marketing, product management, or commercial operations, ideally in rare disease
  • Strong organizational, project management, and communication skills
  • High attention to detail with ability to manage multiple priorities and deadlines
  • Digital fluency – comfortable with CRM systems, analytics platforms, and digital campaign tools
  • Analytical mindset – able to synthesize data and insights to inform decisions
  • Collaborative, flexible, and proactive – thrives in a dynamic, fast-paced environment
  • Passionate about helping patients with rare diseases and driven by purpose
  • Resourceful and eager to learn – a self-starter who takes ownership and seeks opportunities for growth
  • Graphic design and experience with Adobe Creative Cloud (InDesign, Photoshop, etc.) a plus

Responsibilities

  • Partner with the Marketing Director to execute the annual brand plans for CTEXLI and CHOLBAM
  • Assist in developing marketing materials (HCP, patient/caregiver, digital) in alignment with strategic objectives and compliance standards
  • Support execution of omnichannel marketing initiatives, including HCP and patient campaigns, digital content, CRM/email marketing, and social media
  • Coordinate review and approval (MLR) processes, ensuring materials are accurate, timely, and compliant
  • Support tactical execution of field force tools and branded and unbranded education initiatives
  • Manage creative and digital agency partners, ensuring deliverables are high-quality, compliant, and on-time
  • Support ongoing field team enablement through tools, resources, and internal communications
  • Maintain awareness of emerging digital tools and rare disease engagement innovations
  • Help maintain brand budgets and timelines
  • Coordinate logistics for congresses, speaker programs, and HCP & patient events
  • Prepare summaries, presentations, and reports for leadership and brand review meetings
  • Work closely with cross-functional partners (Medical Affairs, Market Access, Patient Services, Commercial Operations, and Field Teams) to ensure alignment and seamless execution

Skills

Digital Marketing
Omnichannel Marketing
CRM
Email Marketing
Social Media
MLR Review
Agency Management
Brand Planning
Budget Management
Marketing Compliance

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI